Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olfr708 Inhibitors

Olfr708, a member of the olfactory receptor family in Mus musculus (house mouse), holds a crucial role in the perception of odors. Much like other olfactory receptors, Olfr708 belongs to the G-protein-coupled receptor (GPCR) family, distinguished by a 7-transmembrane domain structure. These receptors are indispensable for detecting odorant molecules and initiating neuronal responses via G protein-mediated transduction. In the mouse genome, the olfactory receptor gene family stands as the largest, underscoring its significance in the olfactory system. The nomenclature for olfactory receptor genes and proteins in mice is unique, highlighting the distinct diversity and functionality of these receptors.

Inhibiting Olfr708 can be achieved through various mechanisms, primarily focusing on indirect modulation due to the limited availability of direct inhibitors. Compounds such as Tetrodotoxin and Cycloheximide can influence Olfr708 by affecting neuronal signaling and protein synthesis, respectively. Additionally, inhibitors like Suramin and Propranolol, which target GPCR signaling pathways, may indirectly impact Olfr708 function. Furthermore, compounds such as Wortmannin and LY294002 have the potential to inhibit Olfr708 by influencing the PI3K/Akt pathway, which can be involved in olfactory receptor signaling. These inhibitors offer promising avenues for research into controlling olfactory receptor responses in mice, contributing to a deeper understanding of the intricacies of olfaction. In conclusion, Olfr708 plays a pivotal role in the perception of odors in mice, standing as a significant member of the olfactory receptor gene family. Inhibition of Olfr708 can be achieved indirectly through various chemical compounds that influence GPCR signaling, protein synthesis, and associated intracellular pathways. Further exploration is needed to unravel the precise mechanisms of Olfr708 inhibition and their potential applications in deciphering the complexities of olfactory processes in mice.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Cycloheximide is a protein synthesis inhibitor that could potentially affect Olfr708 indirectly by disrupting the synthesis of proteins involved in olfactory signaling pathways.

Suramin sodium

129-46-4sc-507209
sc-507209F
sc-507209A
sc-507209B
sc-507209C
sc-507209D
sc-507209E
50 mg
100 mg
250 mg
1 g
10 g
25 g
50 g
$152.00
$214.00
$728.00
$2601.00
$10965.00
$21838.00
$41096.00
5
(1)

Suramin is a non-specific GPCR antagonist. It might indirectly inhibit Olfr708 by interfering with GPCR signaling, which plays a role in olfactory receptor function.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram is a selective phosphodiesterase 4 (PDE4) inhibitor. By regulating cAMP levels, it may indirectly influence Olfr708, which is involved in cAMP-mediated signal transduction.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin is a potent PI3-kinase inhibitor. It may indirectly inhibit Olfr708 by affecting the PI3K/Akt pathway, which can be involved in olfactory receptor signaling.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 inhibits MEK1, a kinase in the MAPK pathway. Olfr708 may be indirectly modulated by this inhibitor, as it interacts with downstream components of this pathway.

SQ 22536

17318-31-9sc-201572
sc-201572A
5 mg
25 mg
$95.00
$363.00
13
(1)

SQ22536 is an adenylate cyclase inhibitor, reducing cAMP levels. Olfr708, dependent on cAMP signaling, may be indirectly influenced by this compound.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3-kinase inhibitor, potentially affecting the PI3K/Akt pathway, which might indirectly modulate Olfr708, involved in cellular processes influenced by this pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 inhibits p38 MAPK, part of the MAPK pathway. Olfr708 may be indirectly affected due to its association with this pathway.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol is a non-selective beta-blocker. It might indirectly affect Olfr708, as beta-adrenergic receptors are linked to GPCR signaling pathways that could interact with olfactory receptors.

Gallein

2103-64-2sc-202631
50 mg
$85.00
20
(1)

Gallein inhibits Gβγ-mediated signaling, which is crucial for olfactory receptor function. It could potentially affect Olfr708 by disrupting GPCR signaling pathways.